WCM
GILD icon

Weaver Capital Management’s Gilead Sciences GILD Stock Holding History

Weaver Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Hold
1,630
– – 0.05% 144
2026
Q1 		$227K Sell
1,630
-62
-4% -$8.68K 0.05% 146
2025
Q4 		$208K Buy
+1,692
New +$206K 0.04% 160

Other funds holding GILD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Weaver Capital Management's GILD Position: Q2 2026 in Review

Weaver Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,630 shares worth $227K. The position accounts for 0.05% of the portfolio, ranked #144.

Weaver Capital Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 1,323 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Weaver Capital Management held 1,630 shares of Gilead Sciences worth $227K as of Q2 2026.
  • Weaver Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.05% of Weaver Capital Management's portfolio in Q2 2026, its #144 holding.
  • Weaver Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 1,323 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Weaver Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.